Diabetic mice show an aggravated course of herpes-simplex virus-induced facial nerve paralysis

Otology and Neurotology

Volumn 33, Issue 8, 2012, Pages 1452-1457

  Esaki, Shinichi ^a,b   Yamano, Koji ^a   Kiguchi, Jun ^a   Katsumi, Sachiyo ^a   Keceli, Sumru ^a,c   Okamoto, Hideyuki ^c   Goshima, Fumi ^b   Kimura, Hiroshi ^b   Nishiyama, Yukihiro ^b   Murakami, Shingo ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Bell's palsy; Diabetes mellitus; Herpes simplex virus

Indexed keywords

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; ELECTROMYOGRAPHY; EXPERIMENTAL DIABETES MELLITUS; EXTERNAL EAR; FACIAL NERVE; FACIAL NERVE DISEASE; FACIAL NERVE PARALYSIS; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; MOUSE; PATHOLOGY; PHYSIOLOGY; REFLEX; TRANSMISSION ELECTRON MICROSCOPY; VIBRISSA;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; EAR AURICLE; ELECTROMYOGRAPHY; FACIAL NERVE; FACIAL NERVE DISEASES; FACIAL PARALYSIS; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; REFLEX; VIBRISSAE;

EID: 84866601481     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e318268d54d     Document Type: Article

References (20)

1. Gilden DH. Clinical practice. Bell's Palsy. N Engl J Med 2004; 351:1323-31.
2. Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 2002:4-30.
3. Takahashi H, Hitsumoto Y, Honda N, et al. Mouse model of Bell's palsy induced by reactivation of herpes simplex virus type J Neuropathol Exp Neurol 2001;60:621-7.
4. Sugita T, Murakami S, Yanagihara N, Fujiwara Y, Hirata Y, Kurata T. Facial nerve paralysis induced by herpes simplex virus in mice: an animal model of acute and transient facial paralysis. Ann Otol Rhinol Laryngol 1995;104:574-81.
5. Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996;124:27-30.
6. Yanagihara N, Hyodo M. Association of diabetes mellitus and hypertension with Bell's palsy and Ramsay Hunt syndrome. Ann Otol Rhinol Laryngol Suppl 1988;137:5-7.
7. Kanazawa A, Haginomori S, Takamaki A, Nonaka R, Araki M, Takenaka H. Prognosis for Bell's palsy: a comparison of diabetic and nondiabetic patients. Acta Otolaryngol 2007;127:888-91.
8. Hato N, Hitsumoto Y, Honda N, Murakami S, Yanagihara N. Immunologic aspects of facial nerve paralysis induced by herpes simplex virus infection in mice. Ann Otol Rhinol Laryngol 1998; 107:633-7.
9. Murakami S, Hato N, Mizobuchi M, Doi T, Yanagihara N. Role of herpes simplex virus infection in the pathogenesis of facial paralysis in mice. Ann Otol Rhinol Laryngol 1996;105:49-53.
10. Watanabe K, Hagura R, Akanuma Y, et al. Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract 1990; 10:19-27.
11. Hopf HC, Gutmann L. Diabetic 3rd nerve palsy: evidence for a mesencephalic lesion. Neurology 1990;40:1041-5.
12. Malone JI, Lowitt S, Salem AF, Miranda C, Korthals JK, Carver J. The effects of acetyl-L-carnitine and sorbinil on peripheral nerve structure, chemistry, and function in experimental diabetes. Metabolism Clin Exp 1996;45:902-7.
13. Greene DA, Arezzo JC, Brown MB. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group. Neurology 1999;53:580-91.
14. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 1994;70:138-51.
15. Takahashi M, Lu YB, Myint T, Fujii J, Wada Y, Taniguchi N. In vivo glycation of aldehyde reductase, a major 3-deoxyglucosone reducing enzyme: identification of glycation sites. Biochemistry 1995;34:1433-8.
16. Poduslo JF, Curran GL. Increased permeability across the bloodnerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy. Proceedings of the National Academy of Sciences of the United States of America. Proc Natl Acad Sci U S A 1992;89:2218-22.
17. Poduslo JF, Curran GL, Dyck PJ. Increase in albumin, IgG, and IgM blood-nerve barrier indices in human diabetic neuropathy. Proceedings of the National Academy of Sciences of the United States of America. Proc Natl Acad Sci U S A 1988;85:4879-83.
18. Rechthand E, Smith QR, Latker CH, Rapoport SI. Altered bloodnerve barrier permeability to small molecules in experimental diabetes mellitus. J Neuropathol Exp Neurol 1987;46:302-14.
19. Hotta N, Koh N, Sakakibara F, et al. Prevention of abnormalities in motor nerve conduction and nerve blood-flow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic rats. Prostaglandins 1995;49:339-49.
20. Bradbury MW, Lightman SL, Yuen L, Pinter GG. Permeability of blood-brain and blood-nerve barriers in experimental diabetes mellitus in the anaesthetized rat. Exp Physiol 1991;76:887-98.